Chromosome 3 open reading frame 36 (C3orf36)

Chromosome 3 open reading frame 36 (C3orf36) encodes an uncharacterized human protein. The gene is also known by aliases such as FLJ22173 and Uncharacterized protein C3orf36. There is extremely limited information about its molecular function or biological role in public scientific resources. Some sources indicate weak functional evidence for MA protein binding, but no canonical domains, functions, or disease involvements have been defined for this gene[7][9]. It is not currently considered a therapeutic target, nor is it classified into major protein families such as receptors, enzymes, or transcription factors. No drugs, biomarkers, or clinical safety issues have been reported in association with C3orf36. Notes on ambiguity or related genes: C3orf36 is distinct from C4orf36 (Chromosome 4 open reading frame 36), which has more extensive annotation, so care must be taken not to confuse the two[2][6]. SLCO2A1 (Solute Carrier Organic Anion Transporter Family Member 2A1) appears together with C3orf36 in some genotyping product listings but is a separate gene and not an alias or molecular classification for C3orf36[3][5]. Summary: C3orf36 is an uncharacterized protein with unknown function, not currently recognized as a therapeutic target or disease biomarker. There are no reported drug interactions, mechanisms of action, or safety concerns, and its molecular classification remains "Other" due to lack of substantive functional annotation.

Other names

C3orf36Uncharacterized protein C3orf36FLJ22173